scholarly journals Sagittal balance: from theory to clinical practice

2021 ◽  
Vol 6 (12) ◽  
pp. 1193-1202
Author(s):  
Juan I. Cirillo Totera ◽  
José G. Fleiderman Valenzuela ◽  
Jorge A. Garrido Arancibia ◽  
Samuel T. Pantoja Contreras ◽  
Lyonel Beaulieu Lalanne ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Decision Making ◽  
Clinical Practice ◽  
Chronic Disease ◽  
Sagittal Balance ◽  
Sagittal Profile ◽  
Therapeutic Decision ◽  
Basic Principles ◽  
Therapeutic Decision Making

Adequate sagittal balance (SB) is essential to maintain an upright, efficient, and painless posture. It has been shown that sagittal profile alterations affect quality of life of patients with a similar or even greater impact than chronic disease. Evaluation of the SB has gained much relevance in recent years, with recognition of its importance in the evaluation of spinal pathology. This review summarizes the basic principles of SB, aiming to obtain a practical, simple and understandable evaluation of the sagittal profile of a patient. SB is a dynamic process that involves a varying degree of energy expenditure. Distinguishing between a balanced, compensated imbalance or decompensated imbalanced patient, is relevant to diagnosis and therapeutic decision-making. Cite this article: EFORT Open Rev 2021;6:1193-1202. DOI: 10.1302/2058-5241.6.210062

Cancer- and Treatment-Related Anemia Clinical Practice Guidelines in Oncology

2005 ◽  
Vol 3 (6) ◽  
pp. 772 ◽  
Keyword(s):  
Quality Of Life ◽  
Clinical Practice ◽  
Chronic Disease ◽  
Treatment Outcomes ◽  
Clinical Practice Guidelines ◽  
Practice Guidelines ◽  
Patients With Cancer ◽  
Recent Version

Cancer- and treatment-related anemia has received increasing attention, particularly because relationships between anemia and quality of life (QOL) or treatment outcomes are under investigation. This guideline recognizes the multiple etiologies of cancer- and treatment-related anemia, but specifically addresses the treatment of anemia caused by the myelosuppressive effects of chemotherapy and the anemia associated with chronic disease. It provides guidelines for the use of erythropoietic agents in patients with cancer who are receiving chemotherapy. For the most recent version of the guidelines, please visit NCCN.org

scholarly journals Osteoporosis in Human Immunodeficiency Virus Patients – An Emerging Clinical Concern

2010 ◽  
Vol 10 (1) ◽  
pp. 79 ◽  
Author(s):  
Filippo Maffezzoni ◽  
Teresa Porcelli ◽  
Ioannis Karamouzis ◽  
Eugenia Quiros-Roldan ◽  
Francesco Castelli ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Human Immunodeficiency Virus ◽  
Clinical Practice ◽  
Chronic Disease ◽  
Hiv Infection ◽  
Fragility Fractures ◽  
Skeletal Fragility ◽  
Highly Active ◽  
Immunodeficiency Virus

The advent of highly active anti-retroviral therapy (HAART) has significantly improved the survival of human immunodeficiency virus (HIV)-infected patients transforming the HIV infection from a fatal illness into a manageable chronic disease. As the number of older HIV-infected individuals increases, several ageing-related co-morbidities including osteopenia/osteoporosis and fractures have emerged. Patients exposed to HIV infection and its treatment may develop fragility fractures with potential significant impact on quality of life and survival. However, the awareness of HIV-related skeletal fragility is still relatively low and most HIV-infected patients are not investigated for osteoporosis and treated with anti-osteoporotic drugs in daily clinical practice. This article reviews the literature data on osteoporosis and osteopenia in HIV infection, focusing on the pathophysiological, clinical and therapeutic aspects of fragility fractures.

scholarly journals Osteoporosis in Human Immunodeficiency Virus Patients – An Emerging Clinical Concern

2014 ◽  
Vol 10 (01) ◽  
pp. 84 ◽  
Author(s):  
Filippo Maffezzoni ◽  
Teresa Porcelli ◽  
Ioannis Karamouzis ◽  
Eugenia Quiros-Roldan ◽  
Francesco Castelli ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Human Immunodeficiency Virus ◽  
Clinical Practice ◽  
Chronic Disease ◽  
Hiv Infection ◽  
Fragility Fractures ◽  
Skeletal Fragility ◽  
Highly Active ◽  
Immunodeficiency Virus

The advent of highly active anti-retroviral therapy (HAART) has significantly improved the survival of human immunodeficiency virus (HIV)- infected patients transforming the HIV infection from a fatal illness into a manageable chronic disease. As the number of older HIV-infected individuals increases, several aging-related co-morbidities including osteopenia/osteoporosis and fractures have emerged. Patients exposed to HIV infection and its treatment may develop fragility fractures with potential significant impact on quality of life and survival. However, the awareness of HIV-related skeletal fragility is still relatively low and most HIV-infected patients are not investigated for osteoporosis and treated with anti-osteoporotic drugs in daily clinical practice. This article reviews the literature data on osteoporosis and osteopenia in HIV infection, focusing on the pathophysiological, clinical, and therapeutic aspects of fragility fractures.

Sign in / Sign up

Export Citation Format

Share Document